Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiyo Kagaku develops, manufactures, and markets over two thousand food formulations, processed eggs, fruit preparations, flavorings, emulsifiers, stabilizers, tea-based products (notably matcha), carotene-rich sweet potato derivatives, and highly functional food/pharmaceutical ingredients. The company has conducted human studies on its dietary fibers (such as partially hydrolyzed guar gum), plant extracts for oral health improvement, and L-theanine for mood support. Their products are widely used in the global food industry as well as in nutraceuticals/supplements. They have received multiple awards for innovation in emulsifiers and delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiyo Kagaku.